DNLI240517P00020000 Option on Denali Therapeutics
| DNLI Stock | USD 18.46 0.42 2.33% |
Denali Therapeutics' option chain provides insight into all available option contracts written on Denali Therapeutics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Denali Therapeutics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Denali option contract.
In The Money vs. Out of Money Option Contracts on Denali Therapeutics
Analyzing Denali Therapeutics' in-the-money options over time can help investors to take a profitable long position in Denali Therapeutics regardless of its overall volatility. This is especially true when Denali Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Denali Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Denali Therapeutics' stock while costing only a fraction of its price.
Denali Therapeutics' latest option contracts expiring on 2024-06-21 are carrying combined implied volatility of 75.08 with a put-to-call open interest ratio of 0.3 over 24 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-06-21. The current put volume is at 0, with calls trading at the volume of 7. This yields a 0.0 put-to-call volume ratio. The Denali Therapeutics option chain provides detailed quote and price information for the current Denali Therapeutics option contracts. It shows all of Denali Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-06-21 Option Contracts
Denali Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Denali Therapeutics' lending market. For example, when Denali Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Denali Therapeutics, he or she must hedge the risk by shorting Denali Therapeutics stock over its option's life.
2024-06-21
The chart above shows Denali Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Denali Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Denali Therapeutics' option, there is no secondary market available for investors to trade.
Denali Therapeutics' stock options are financial instruments that give investors the right to buy or sell shares of Denali Therapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Denali stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Denali Therapeutics' stock price goes up or down, the stock options follow.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. Please note that buying 'in-the-money' options on Denali Therapeutics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Denali Therapeutics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Denali Therapeutics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Denali Stock moves the wrong way.
The Denali Therapeutics' current Stock Based Compensation is estimated to increase to about 113.5 M, while Total Stockholder Equity is projected to decrease to under 712.9 M. Denali Therapeutics In The Money Call Balance
When Denali Therapeutics' strike price is surpassing the current stock price, the option contract against Denali Therapeutics stock is said to be in the money. When it comes to buying Denali Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Denali Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Denali Current Options Market Mood
Denali Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Denali Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Denali Therapeutics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Denali Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Denali Therapeutics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Denali contract
Base on the Rule 16, the options market is currently suggesting that Denali Therapeutics will have an average daily up or down price movement of about 4.69% per day over the life of the 2024-06-21 option contract. With Denali Therapeutics trading at USD 18.46, that is roughly USD 0.87. If you think that the market is fully incorporating Denali Therapeutics' daily price movement you should consider buying Denali Therapeutics options at the current volatility level of 75.08%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Denali |
Purchasing Denali Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Denali calls. Remember, the seller must deliver Denali Therapeutics stock to the call owner when a call is exercised.
Denali Therapeutics Option Chain
When Denali Therapeutics' strike price is surpassing the current stock price, the option contract against Denali Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Denali Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Denali. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Denali. It also shows strike prices and maturity days for a Denali Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-06-21 CALL at $2.5 | 0.9888 | 0.0013 | 0 | 2024-06-21 | 14.2 - 18.0 | 0.0 | In |
Call | 2024-06-21 CALL at $5.0 | 0.9941 | 0.0015 | 0 | 2024-06-21 | 11.8 - 15.2 | 0.0 | In |
Call | 2024-06-21 CALL at $7.5 | 0.9825 | 0.0048 | 0 | 2024-06-21 | 9.1 - 13.0 | 0.0 | In |
Call | 2024-06-21 CALL at $10.0 | 0.9562 | 0.0123 | 0 | 2024-06-21 | 7.1 - 10.2 | 0.0 | In |
Call | 2024-06-21 CALL at $12.5 | 0.9278 | 0.0248 | 0 | 2024-06-21 | 4.4 - 8.0 | 0.0 | In |
Call | 2024-06-21 CALL at $15.0 | 0.8066 | 0.0507 | 2 | 2024-06-21 | 2.85 - 5.5 | 6.8 | In |
Call | 2024-06-21 CALL at $17.5 | 0.6696 | 0.1253 | 33 | 2024-06-21 | 1.45 - 2.25 | 1.7 | In |
Call | 2024-06-21 CALL at $20.0 | 0.3291 | 0.1315 | 513 | 2024-06-21 | 0.5 - 1.1 | 0.55 | Out |
Call | 2024-06-21 CALL at $22.5 | 0.1924 | 0.0737 | 473 | 2024-06-21 | 0.0 - 0.5 | 0.36 | Out |
Call | 2024-06-21 CALL at $25.0 | 0.1097 | 0.0454 | 1305 | 2024-06-21 | 0.05 - 0.6 | 0.2 | Out |
Put | 2024-06-21 PUT at $17.5 | -0.341 | 0.115 | 202 | 2024-06-21 | 0.2 - 1.4 | 0.8 | Out |
Put | 2024-06-21 PUT at $20.0 | -0.6347 | 0.1137 | 370 | 2024-06-21 | 1.55 - 2.95 | 1.3 | In |
Put | 2024-06-21 PUT at $22.5 | -0.7968 | 0.0733 | 2 | 2024-06-21 | 3.6 - 5.2 | 3.5 | In |
Put | 2024-06-21 PUT at $25.0 | -0.7298 | 0.0477 | 100 | 2024-06-21 | 6.0 - 8.9 | 5.2 | In |
Put | 2024-06-21 PUT at $30.0 | -0.7641 | 0.0335 | 6 | 2024-06-21 | 11.0 - 14.0 | 11.6 | In |
Put | 2024-06-21 PUT at $35.0 | -0.861 | 0.0251 | 0 | 2024-06-21 | 15.0 - 19.0 | 0.0 | In |
Denali Therapeutics Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Denali Therapeutics Common Stock Total Equity Over Time
The total value of common stock equity held by shareholders, representing their ownership interest in the company. Common Stock Total Equity |
| Timeline |
Denali Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Denali Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Denali Therapeutics Corporate Management
Elected by the shareholders, the Denali Therapeutics' board of directors comprises two types of representatives: Denali Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Denali. The board's role is to monitor Denali Therapeutics' management team and ensure that shareholders' interests are well served. Denali Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Denali Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Chin | Senior Affairs | Profile | |
| Carole MD | Chief Development | Profile | |
| Mark Rowen | Vice Development | Profile | |
| Chris Walsh | General Counsel | Profile |
Already Invested in Denali Therapeutics?
The danger of trading Denali Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Denali Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Denali Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Denali Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Denali Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Denali Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Denali Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Denali Therapeutics Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Denali Stock analysis
When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is Denali Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share 2.101 | Quarterly Revenue Growth (1.00) | Return On Assets (0.09) | Return On Equity (0.11) |
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.